NasdaqGS:ICUI

Stock Analysis Report

Executive Summary

ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide.

Snowflake

Fundamentals

Flawless balance sheet and fair value.

Risks

  • ICU Medical has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has ICU Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.1%

NasdaqGS:ICUI

2.9%

US Medical Equipment

2.9%

US Market


1 Year Return

-45.1%

NasdaqGS:ICUI

14.0%

US Medical Equipment

0.2%

US Market

ICUI underperformed the Medical Equipment industry which returned 14.1% over the past year.

ICUI underperformed the Market in United States of America which returned -0.7% over the past year.


Share holder returns

ICUIIndustryMarket
7 Day0.1%2.9%2.9%
30 Day-34.2%0.8%-2.3%
90 Day-26.5%11.3%3.1%
1 Year-45.1%-45.1%14.9%14.0%2.4%0.2%
3 Year35.0%35.0%71.4%66.1%41.7%32.4%
5 Year162.1%162.1%134.0%107.1%55.1%37.9%

Price Volatility Vs. Market

How volatile is ICU Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is ICU Medical undervalued based on future cash flows and its price relative to the stock market?

46%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

ICU Medical's share price is below the future cash flow value, and at a moderate discount (> 20%).

ICU Medical's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

ICU Medical is overvalued based on earnings compared to the US Medical Equipment industry average.

ICU Medical is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

ICU Medical is poor value based on expected growth next year.


Price Based on Value of Assets

ICU Medical is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is ICU Medical expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

38.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

ICU Medical's revenue is expected to grow by 0.2% yearly, however this is not considered high growth (20% yearly).

ICU Medical's earnings are expected to grow significantly at over 20% yearly.

ICU Medical's revenue growth is positive but not above the United States of America market average.

ICU Medical's earnings growth is expected to exceed the United States of America market average.

ICU Medical's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

ICU Medical is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has ICU Medical performed over the past 5 years?

9.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

ICU Medical's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.

ICU Medical's 1-year earnings growth is negative, it can't be compared to the 5-year average.

ICU Medical's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.


Return on Equity

ICU Medical has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

ICU Medical used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

ICU Medical's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is ICU Medical's financial position?


Financial Position Analysis

ICU Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

ICU Medical's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

ICU Medical has no debt.

ICU Medical currently has no debt however we can't compare to 5 years ago as we have no data for that period.

ICU Medical has no debt, it does not need to be covered by operating cash flow.

ICU Medical has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

ICU Medical has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is ICU Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate ICU Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate ICU Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as ICU Medical has not reported any payouts.

Unable to verify if ICU Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as ICU Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of ICU Medical's salary, the management and board of directors tenure and is there insider trading?

2.5yrs

Average management tenure


CEO

Vivek Jain (47yo)

5.5yrs

Tenure

US$5,962,408

Compensation

Mr. Vivek Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr. Jain served as the President of Procedural Solutions at CareFusion Corporation from August 201 ...


CEO Compensation Analysis

Vivek's remuneration is about average for companies of similar size in United States of America.

Vivek's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Management Age and Tenure

2.5yrs

Average Tenure

53.5yo

Average Age

The tenure for the ICU Medical management team is about average.


Board Age and Tenure

4.5yrs

Average Tenure

58yo

Average Age

The tenure for the ICU Medical board of directors is about average.


Insider Trading

ICU Medical individual insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$719,09111 Jun 19
Kevin McGrody
EntityIndividual
Role
Controller
Controller
Shares3,101
Max PriceUS$231.89
SellUS$1,217,13914 May 19
Christian Voigtlander
EntityIndividual
Role
Chief Operating Officer
Chief Operating Officer
Shares5,348
Max PriceUS$228.07
SellUS$343,52818 Mar 19
Robert Swinney
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,464
Max PriceUS$234.65
SellUS$523,125,00016 Nov 18
Pfizer Inc.
EntityCompany
Shares2,500,000
Max PriceUS$209.25
SellUS$238,55529 Aug 18
Virginia Sanzone
EntityIndividual
Role
Chief Legal Officer
Corporate VP
Shares787
Max PriceUS$303.12

Ownership Breakdown


Management Team

  • Steve Riggs (60yo)

    Executive Officer of Special Project Opertions

    • Tenure: 0.0yrs
    • Compensation: US$1.05m
  • Scott Lamb (56yo)

    CFO & Treasurer

    • Tenure: 11.5yrs
    • Compensation: US$1.63m
  • Vivek Jain (47yo)

    Chairman of the Board & CEO

    • Tenure: 5.5yrs
    • Compensation: US$5.96m
  • Kevin McGrody

    Controller

    • Tenure: 0.0yrs
  • Tom McCall (61yo)

    Corporate Vice President of Marketing & Communications and GM of Critical Care

    • Tenure: 2.5yrs
    • Compensation: US$980.28k
  • Virginia Sanzone (44yo)

    Corporate VP

    • Tenure: 1.6yrs
    • Compensation: US$1.47m
  • Christian Voigtlander (51yo)

    Chief Operating Officer

    • Tenure: 1.6yrs
    • Compensation: US$2.74m

Board Members

  • Elisha Finney (58yo)

    Independent Director

    • Tenure: 3.6yrs
    • Compensation: US$267.05k
  • George Lopez (71yo)

    Director

    • Tenure: 35.6yrs
    • Compensation: US$368.15k
  • Robert Swinney (73yo)

    Independent Director

    • Tenure: 21.6yrs
    • Compensation: US$256.30k
  • David Hoffmeister (64yo)

    Independent Director

    • Tenure: 1.6yrs
    • Compensation: US$240.05k
  • Vivek Jain (47yo)

    Chairman of the Board & CEO

    • Tenure: 5.5yrs
    • Compensation: US$5.96m
  • David Greenberg (52yo)

    Lead Independent Director

    • Tenure: 0.0yrs
    • Compensation: US$271.05k
  • Don Abbey (52yo)

    Independent Director

    • Tenure: 1.6yrs
    • Compensation: US$240.05k

Company Information

ICU Medical, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ICU Medical, Inc.
  • Ticker: ICUI
  • Exchange: NasdaqGS
  • Founded: 1984
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$3.409b
  • Shares outstanding: 20.67m
  • Website: https://www.icumed.com

Number of Employees


Location

  • ICU Medical, Inc.
  • 951 Calle Amanecer
  • San Clemente
  • California
  • 92673
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ICUINasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDMar 1992
IC7DB (Deutsche Boerse AG)YesCommon StockDEEURMar 1992

Biography

ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube runni ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/21 23:38
End of Day Share Price2019/08/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.